BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 11, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Lescol fluvastatin: Pilot trial data

Researchers at Filantropia Municipal Hospital and colleagues reported data from a double-blind pilot trial in 209 treatment-naïve patients with chronic HCV genotype 1 infection showing that a significantly greater proportion of patients receiving 20 mg fluvastatin plus standard of care (SOC; Pegasys peginterferon alfa-2a...

Read the full 210 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >